Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 8 clinical trials
Feasibility of Low Energy Diet in HFpEF and Type 2 Diabetes (ALLEVIATE)

Open, Single arm intervention, feasibility study

  • 0 views
  • 09 Jun, 2022
  • 1 location
Personalized Medicine for Membranous Nephropathy (PMMN)

antiproteinuric therapy, and if the nephrotic syndrome persists at month-6 (urinary protein/creatinine ratio (UPCR) remains > 3.5 g/g and albuminemia < 30 g/l), two 375 mg/m2 rituximab infusions at 1-week

proteinuria
angiotensin
rituximab
diuretics
remission
  • 49 views
  • 27 Feb, 2022
  • 2 locations
Preeclampsia Postpartum Antihypertensive Treatment

The goal of this study is to compare whether antihypertensive treatment in the postpartum period decreases postpartum hypertension and its associated maternal morbidity, including risk of readmission and healthcare utilization in comparison with no treatment. Women with preeclampsia diagnosed during the antepartum, intrapartum or postpartum period will be randomized to …

antihypertensive drugs
nifedipine
labetalol
hypertension
  • 22 views
  • 16 Dec, 2021
  • 1 location
Comparison of BTD and BCD Based Regimens in the Treatment of AL Amyloidosis

Research Objective:At present, there is no standard therapeutic regimen for monoclonal immunoglobulin light chain (AL) amyloidosis in the world. To compare the efficacy and safety of the regimens between bortezomib-thalidomide-dexamethasone (BTD) and bortezomib-cyclophosphamide-dexamethasone (BCD) in the treatment of AL amyloidosis, so as to provide more clinical evidence for the standard …

electrophoresis
thalidomide
cyclophosphamide
dexamethasone
bone marrow procedure
  • 0 views
  • 26 Jan, 2021
  • 1 location
DAPAgliflozin for Renal Protection in Heart Transplant Recipients (DAPARHT)

Kidney failure is common in heart transplant recipients and is a major cause of morbidity and mortality. Sodium-glucose transporter 2 (SGLT2) inhibitors were developed as antidiabetics but were subsequently shown to reduce the incidence of adverse cardiovascular outcomes and protect renal function in non-diabetics as well as diabetics. However, SGLT2 …

diabetes
cancer
proteinuria
  • 0 views
  • 07 Oct, 2022
  • 1 location
Chinese Cohort Study of Chronic Kidney Disease (C-STRIDE)

This study aimed to explore underlying mechanisms of chronic kidney disease progression and its association with adverse consequences. It will enroll approximately 5000 pre-dialysis chronic kidney disease patients aged between 18 and 74 years in mainland China and follow-up for at least 5 years. Questionnaires, anthropometric measures, laboratory tests, and …

nephropathy
glomerular filtration rate
proteinuria
dialysis
  • 8 views
  • 18 May, 2022
  • 1 location
Early Screening and Diagnosis of CKD

detect thrice albumin-creatinine ratio (ACR) within three months, with simultaneous test of urinary protein-creatinine ratio (PCR), 24-hour urine protein excretion rate (PER) and 24-hour albumin albumin

nephropathy
cystatin c
glomerular filtration rate
  • 13 views
  • 27 Apr, 2022
  • 1 location
Troponin Excretion in Urine in Patients With and Without Chronic Kidney Disease

In this study, in order to better understand the mechanism of troponin clearance and the reason for elevated troponin levels in patients with CKD, we aim to evaluate quantitatively the excretion of troponin in the urine in patients with and without CKD, and with and without myocardial injury. We will …

nephropathy
troponin
myocardial injury
Accepts healthy volunteers
  • 0 views
  • 04 Oct, 2022
  • 1 location